The overexpression observed in peripheral cells of patients compared to CS may also be directly associated with the ability of IL-17A to induce the expression of CXCR4 since elevated serum levels of this cytokine have also been described in patients with RA [27]. The gene discussed is CXCR4; the disease is rheumatoid arthritis.